Caris Life Sciences, Inc. (CAI)
19.58
-0.36
(-1.81%)
USD |
NASDAQ |
Nov 18, 13:48
Caris Life Sciences Cash and Short Term Investments (Quarterly) : 767.38M for Sept. 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 767.38M |
| June 30, 2026 | 793.12M |
| March 31, 2026 | 823.46M |
| December 31, 2025 | 800.09M |
| Date | Value |
|---|---|
| September 30, 2025 | 757.01M |
| June 30, 2025 | 722.69M |
| March 31, 2025 | 34.93M |
| December 31, 2024 | 67.64M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Natera, Inc. | 1.097B |
| Myriad Genetics, Inc. | 107.10M |
| BioRestorative Therapies, Inc. | 3.592M |
| CareDx, Inc. | 250.48M |
| Exagen, Inc. | 28.09M |